Cargando…
MOMC-2. Glioblastoma Metabolic Symbiosis: When Lactate Takes The Lead
Glioblastoma (GBM) is a common and devastating brain tumor, associated with a low median survival, despite standard therapeutic management. Among its major features, GBMs are highly angiogenic and exhibit paradoxically an elevated glycolysis. Most of differentiated cells convert glucose into pyruvat...
Autores principales: | Guyon, Joris, Larrieu, Claire, Bouchez, Cyrielle, Moncada, Ignacio Fernandez, Coffe, Aurelien, Nikolski, Macha, Bikfalvi, Andreas, Daubon, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255464/ http://dx.doi.org/10.1093/noajnl/vdab070.012 |
Ejemplares similares
-
FSMP-14. METABOLIC SYMBIOSIS IN GLIOBLASTOMA: LACTATE DEHYDROGENASES TAKE THE LEAD
por: Guyon, Joris, et al.
Publicado: (2021) -
Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis
por: Guyon, Joris, et al.
Publicado: (2022) -
The invasive proteome of glioblastoma revealed by laser-capture microdissection
por: Daubon, Thomas, et al.
Publicado: (2019) -
MOMC-1. Employing the Zika Virus to kill paediatric nervous system tumour cells
por: Sherwood, Matthew, et al.
Publicado: (2021) -
MOMC-5. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
por: Genovesi, Laura, et al.
Publicado: (2021)